ER4 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Emergent BioSolutions Inc

Watchlist Manager

Watchlist

Price: 10.27 EUR -1.77%

Market Cap: €1.9B

E	Emergent BioSolutions Inc XBER:ER4	US
N	Newmax Technology Co Ltd TPEX:3630	TW
P	Pagegroup PLC OTC:MPGPF	UK

Profitability Summary

Emergent BioSolutions Inc's profitability score is 41/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

54%

Sustainable 3Y Average Gross Margin

41%

Gross Margin is Increasing

30% > 54%

Low Operating Margin

Negative 3Y Average Operating Margin

-8%

Operating Margin is Increasing

-31% > 9%

Negative Net Margin

-1%

Negative 3Y Average Net Margin

-25%

Net Margin is Increasing

-64% > -1%

Exceptional Free Cash Flow Margin

20%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-49% > 20%

Negative ROE

-2%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-9%

ROIC is Increasing

-20% > -13%

View All

Hide

Collapse

41 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.